Stephen Rapundalo, PhD - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

Stephen Rapundalo, PhD

Description:

... in Sturgis Amway ... tax and regulatory policies Patience and a long-term perspective An Action Plan for MI s Biosciences Opportunities for Michigan ... – PowerPoint PPT presentation

Number of Views:81
Avg rating:3.0/5.0
Slides: 13
Provided by: icl85
Category:
Tags: phd | amway | plan | rapundalo | stephen

less

Transcript and Presenter's Notes

Title: Stephen Rapundalo, PhD


1
Biosciences in Michigan A High-Tech,
Multi-Sector, Growth Industry
  • Stephen Rapundalo, PhD
  • President and CEO
  • MichBio

2
Introducing the Biosciences
3
A High-Growth Global Industry
  • Biosciences has a strong performance record, even
    in difficult economic and political times
  • outperformed Dow and NASDAQ
  • 85 billion in U.S. revenues
  • Europe 12 billion
  • Asia/Pacific 3 billion
  • Canada 2 billion
  • Pharma remains king
  • twenty products have sales gt 1B gt100 products
    total
  • 350 biotech drugs in late stage clinical trials
  • U.S.-made ag-bio products now grown on 200
    million acres worldwide and growing at 20 per
    year over 1 billion acres have been planted
  • Proven applications in healthcare (cure
    prevention), food/agriculture, and industrial
    (chemicals, fuels materials)

U.S. BioPharma, Biotech, Devices Diagnostics
growth is assured and sustainable on a
demographics basis alone.
4
Biosciences in the U.S.
  • Biosciences are key driver of modern economic
    progress
  • All states and regions are investing to create a
    business climate that supports specific needs of
    biosciences sector
  • Academic RD expenditures 28 billion in FY06
  • VC investments in bio companies 11.6 billion
    in 2007
  • Total U.S. employment of 1.3 million in 2006
  • Total impact (direct, indirect, induced jobs)
    7.5 million
  • Direct-effect employment multiplier 5.8

FierceBiotech 2009 Top Regions Targeting
Biotechnology MN, MA, NY, ON, CO
5
Biosciences in Michigan
  • gt 550 bioscience companies
  • 40,086 direct jobs
  • 33,873 private sector jobs
  • 6,213 jobs in academia
  • 58,721 spinoff jobs
  • directspinoff earnings 6.6 B
  • private sector payroll 2.5B
  • private sector tax revenues 0.5 B
  • 9.3 B to states GRP
  • 73,930 avg. bio salary
  • 11.1 B in sales for MI companies w/ HQs
  • four Fortune 500 bioscience companies (Dow,
    Delphi, Kellogg, Stryker)

Biosciences is big business in Michigan
6
Global Bio-Industry Leaders in MI
  • Abbott owns Abbott Nutrition (formerly Ross
    Labs) in Sturgis
  • Amway nutraceuticals in Grand Rapids
  • Bayer owns Bayer Crop Science facility in
    Muskegon
  • Beckman-Coulter owns Lumigen in Southfield
  • Becton Dickinson own facility in Detroit
  • Bristol-Myers Squibb owns Mead Johnson
    Nutrition in Zeeland
  • Dow bio-based technologies and chemicals in
    Midland
  • Johnson Johnson owns Healthmedia in Ann
    Arbor
  • Kellogg Battle Creek
  • Nestlé Company owns Gerber Products in Fremont
  • Perrigo worlds 1 OTC manufacturer in Allegan
  • Pfizer largest global manufacturing facility
    in Portage Animal Health RD HQ in Kalamazoo
  • Stryker Portage Kalamazoo
  • Terumo owns Terumo CVS and Terumo Heart in Ann
    Arbor

7
MIs Bio-Industry A Full Spectrum
8
Entrepreneurship in MIs Biosciences
9
MIs Biosciences Stats Rankings
10
MSAs with 10,000 Employees
11
Factors for Success
12
An Action Plan for MIs Biosciences
  • Opportunities for Michigan
  • Formal strategy for development of the
    biosciences sector
  • State legislative committee and/or caucus focused
    on biosciences
  • Program or initiative to support bioscience
    research infrastructure projects Funding to
    attract star executive/management and faculty
    to state
  • Enhance pre-seed funding and other investment
    sourcing for companies
  • Entrepreneurial support program focused on
    biosciences
  • Program or initiative to finance fit-out costs
    for bioscience incubators
  • Novel approaches to address bioscience talent
    needs
  • Tax incentives specific to bioscience companies
    and sector strengths
  • Favorable regulatory policies

?
?
Write a Comment
User Comments (0)
About PowerShow.com